| # | Drug | Count |
|---|---|---|
| 0 | BISOPROLOL FUMARATE | 25 |
| 1 | METFORMIN HYDROCHLORIDE | 15 |
| 2 | METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS | 15 |
| 3 | METFORMIN HYDROCHLORIDE TABLET | 15 |
| 4 | METFORMIN HYDROCHLORIDE TABLETS | 15 |
| 5 | SIMVASTATIN | 15 |
| 6 | SPIRONOLACTONE | 15 |
| 7 | AMLODIPINE | 14 |
| 8 | PANTOPRAZOLE | 14 |
| 9 | TORSEMIDE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | L-ARGININE | 1 | 0.0028 |
| 1 | PONATINIB HYDROCHLORIDE | 11 | 0.0021 |
| 2 | TRAVOPROST | 12 | 0.0014 |
| 3 | NISOLDIPINE | 1 | 0.0008 |
| 4 | PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION | 1 | 0.0008 |
| 5 | ARGATROBAN | 1 | 0.0007 |
| 6 | LAMIVUDINE AND ZIDOVUDINE | 5 | 0.0006 |
| 7 | DESOXIMETASONE | 10 | 0.0005 |
| 8 | PIPERACILLIN SODIUM,TAZOBACTAM SODIUM | 12 | 0.0004 |
| 9 | ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Loop Diuretic [EPC] | 20 |
| 1 | Angiotensin 2 Receptor Blocker [EPC] | 19 |
| 2 | HMG-CoA Reductase Inhibitor [EPC] | 18 |
| 3 | Corticosteroid [EPC] | 17 |
| 4 | Dihydropyridine Calcium Channel Blocker [EPC] | 16 |
| 5 | Aldosterone Antagonist [EPC] | 15 |
| 6 | Osmotic Laxative [EPC] | 15 |
| 7 | Calcium Channel Blocker [EPC] | 14 |
| 8 | Xanthine Oxidase Inhibitor [EPC] | 13 |
| 9 | Angiotensin Converting Enzyme Inhibitor [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 1 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 2 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 3 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 4 | Prostaglandin Analog [EPC] | 12 | 0.0001 |
| 5 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | Protease Inhibitor [EPC] | 5 | 0.0001 |
| 7 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0001 |
| 8 | Aldosterone Antagonist [EPC] | 15 | 0.0001 |
| 9 | Angiotensin Converting Enzyme Inhibitor [EPC] | 12 | 0.0001 |